NovoCure
NVCR
NVCR
85 hedge funds and large institutions have $567M invested in NovoCure in 2017 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
20% more funds holding
Funds holding: 71 → 85 (+14)
13.12% more ownership
Funds ownership: 24.08% → 37.2% (+13%)
Holders
85
Holding in Top 10
4
Calls
$17.7M
Puts
$1.73M
Top Buyers
| 1 | +$85M | |
| 2 | +$40M | |
| 3 | +$21.4M | |
| 4 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$21M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$14.3M |
Top Sellers
| 1 | -$6.31M | |
| 2 | -$5.65M | |
| 3 | -$1.74M | |
| 4 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$1.48M |
| 5 |
HCM
Highline Capital Management
New York
|
-$1.04M |